Stock Analysts’ updated eps estimates for Wednesday, May 6th:
Adaptive Biotechnologies (NASDAQ:ADPT) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $22.00 target price on the stock.
Adaptive Biotechnologies (NASDAQ:ADPT) had its buy rating reissued by analysts at Guggenheim. Guggenheim currently has a $21.00 target price on the stock.
Arista Networks (NYSE:ANET) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $185.00 target price on the stock.
AstraZeneca (LON:AZN) had its sell rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a £115 target price on the stock.
TopBuild (NYSE:BLD) was downgraded by analysts at Loop Capital from a buy rating to a hold rating. They currently have $485.00 price target on the stock.
Bumble (NASDAQ:BMBL) had its sector perform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $5.00 price target on the stock.
Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reiterated by analysts at Berenberg Bank.
Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reiterated by analysts at UBS Group AG.
Anheuser-Busch InBev SA/NV (NYSE:BUD) had its neutral rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reiterated by analysts at Sanford C. Bernstein.
Carlsmed (NASDAQ:CARL) had its buy rating reiterated by analysts at BTIG Research. They currently have a $23.00 target price on the stock.
Rothschild & Co Redburn assumed coverage on shares of Celsius (NASDAQ:CELH). The firm issued a neutral rating and a $47.00 target price on the stock.
Chrysalis Investments (LON:CHRY) had its buy rating reiterated by analysts at Jefferies Financial Group Inc..
Cipher Mining (NASDAQ:CIFR) had its buy rating reiterated by analysts at BTIG Research. They currently have a $25.00 target price on the stock.
Coinbase Global (NASDAQ:COIN) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $240.00 price target on the stock.
Coupang (NYSE:CPNG) was downgraded by analysts at Citigroup Inc. from a buy rating to a neutral rating. The firm currently has $22.20 price target on the stock.
Coupang (NYSE:CPNG) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a buy rating to a hold rating. The firm currently has $23.00 target price on the stock.
Diageo (LON:DGE) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 1,900 target price on the stock.
Dr. Martens (LON:DOCS) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 114 price target on the stock.
Drax Group (LON:DRX) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a GBX 1,000 target price on the stock.
eEnergy Group (LON:EAAS) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 12 price target on the stock.
Enovix (NASDAQ:ENVX) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating.
B. Riley Financial, Inc. assumed coverage on shares of Firefly Aerospace (NASDAQ:FLY). They issued a buy rating and a $60.00 price target on the stock.
First Watch Restaurant Group (NASDAQ:FWRG) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $21.00 price target on the stock.
GSK (LON:GSK) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 1,900 target price on the stock.
Hudson Pacific Properties (NYSE:HPP) had its buy rating reiterated by analysts at BTIG Research. They currently have a $26.00 price target on the stock.
HSBC (LON:HSBA) had its hold rating reissued by analysts at HSBC Holdings plc. HSBC Holdings plc currently has a GBX 1,450 price target on the stock.
Huron Consulting Group (NASDAQ:HURN) had its outperform rating reiterated by analysts at Wedbush. They currently have a $160.00 target price on the stock.
IAC (NASDAQ:IAC) had its neutral rating reaffirmed by analysts at Piper Sandler. They currently have a $48.00 price target on the stock, up from their previous price target of $39.00.
International Business Machines (NYSE:IBM) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $320.00 target price on the stock.
JD Sports Fashion (LON:JD) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 840 target price on the stock.
JD Sports Fashion (LON:JD) had its hold rating reaffirmed by analysts at Shore Capital Group Ltd.
J D Wetherspoon (LON:JDW) had its buy rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 840 target price on the stock.
Joby Aviation (NYSE:JOBY) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $18.00 target price on the stock.
JPMorgan Chase & Co. (NYSE:JPM) had its buy rating reissued by analysts at Barclays PLC.
Kodal Minerals (LON:KOD) had its speculative buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 1.20 price target on the stock.
Canaccord Genuity Group Inc. initiated coverage on shares of Kymera Therapeutics (NASDAQ:KYMR). Canaccord Genuity Group Inc. issued a buy rating and a $106.00 target price on the stock.
Lucid Group (NASDAQ:LCID) was downgraded by analysts at Benchmark Co. from a buy rating to a hold rating.
Logitech International (NASDAQ:LOGI) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $135.00 price target on the stock.
Madrigal Pharmaceuticals (NASDAQ:MDGL) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $620.00 price target on the stock.
Citigroup Inc. assumed coverage on shares of Merck & Co., Inc. (NYSE:MRK). Citigroup Inc. issued a neutral rating and a $125.00 target price on the stock.
Neurocrine Biosciences (NASDAQ:NBIX) had its buy rating reaffirmed by analysts at Guggenheim. The firm currently has a $175.00 target price on the stock.
Norwegian Cruise Line (NYSE:NCLH) was downgraded by analysts at Northcoast Research from a buy rating to a neutral rating.
NIKE (NYSE:NKE) had its neutral rating reaffirmed by analysts at Berenberg Bank.
NEXT (LON:NXT) had its buy rating reissued by analysts at Shore Capital Group Ltd.
Ocular Therapeutix (NASDAQ:OCUL) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $30.00 target price on the stock.
Otter Tail (NASDAQ:OTTR) was downgraded by analysts at Siebert Williams Shank from a buy rating to a hold rating. They currently have $86.00 price target on the stock.
Palo Alto Networks (NASDAQ:PANW) had its buy rating reissued by analysts at Truist Financial Corporation. They currently have a $220.00 target price on the stock, up from their previous target price of $205.00.
Procore Technologies (NYSE:PCOR) had its buy rating reissued by analysts at BTIG Research. The firm currently has a $66.00 price target on the stock.
Pinewood Technologies Group (LON:PINE) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 670 price target on the stock.
Portmeirion Group (LON:PMP) had its house stock rating reissued by analysts at Shore Capital Group Ltd.
PayPal (NASDAQ:PYPL) had its outperform rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $59.00 target price on the stock.
Renishaw (LON:RSW) had its hold rating reaffirmed by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a GBX 3,450 target price on the stock.
Revolve Group (NYSE:RVLV) had its buy rating reissued by analysts at BTIG Research. They currently have a $35.00 price target on the stock.
Sotera Health (NASDAQ:SHC) had its overweight rating reiterated by analysts at Piper Sandler. The firm currently has a $22.00 price target on the stock, down from their previous price target of $24.00.
Shoals Technologies Group (NASDAQ:SHLS) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $12.00 target price on the stock.
Shopify (NASDAQ:SHOP) (TSE:SHOP) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a $170.00 target price on the stock.
Solid Power (NASDAQ:SLDP) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $7.00 target price on the stock.
Super Micro Computer (NASDAQ:SMCI) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $40.00 price target on the stock.
Smiths News (LON:SNWS) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 85 target price on the stock.
Smiths News (LON:SNWS) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 95 target price on the stock.
Solventum (NYSE:SOLV) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $89.00 target price on the stock.
SOPHiA GENETICS (NASDAQ:SOPH) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $8.00 target price on the stock.
Telecom Plus (LON:TEP) had its hold rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 2,000 price target on the stock.
Target Healthcare REIT (LON:THRL) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. They currently have a GBX 101 target price on the stock.
TransMedics Group (NASDAQ:TMDX) was downgraded by analysts at Oppenheimer Holdings, Inc. from an outperform rating to a market perform rating.
T-Mobile US (NASDAQ:TMUS) had its buy rating reiterated by analysts at DZ Bank AG.
Towne Bank (NASDAQ:TOWN) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. The firm currently has a $38.00 price target on the stock, down from their previous price target of $42.00.
Trainline (LON:TRN) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 350 price target on the stock.
Trevi Therapeutics (NASDAQ:TRVI) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $21.00 target price on the stock.
Unilever (LON:ULVR) had its hold rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. They currently have a GBX 5,150 target price on the stock.
Upstart (NASDAQ:UPST) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $43.00 price target on the stock.
Vanquis Banking Group (LON:VANQ) had its buy rating reiterated by analysts at Shore Capital Group Ltd.
Valley National Bancorp (NASDAQ:VLY) had its equal weight rating reiterated by analysts at Morgan Stanley. Morgan Stanley currently has a $15.00 target price on the stock, up from their previous target price of $14.00.
Westlake (NYSE:WLK) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. They currently have $90.00 target price on the stock.
Receive News & Ratings for Adaptive Biotechnologies Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adaptive Biotechnologies Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
